Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -575.70K | 182.10K | -335.60K | -711.60K | -1.59M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 174.10K | -819.90K | 758.10K | 10.40K | 1.37M |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -401.60K | -637.70K | 422.60K | -701.10K | -218.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -1.00M | -- | -- |
| Total Debt Issued | 46.20K | 1.50M | -- | 1.50M | -- |
| Total Debt Repaid | -28.50K | -1.07M | -- | -3.00K | -50.00K |
| Issuance of Common Stock | -- | -- | 128.00K | -- | -- |
| Repurchase of Common Stock | -- | -201.50K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 60.00K | -7.00K | -- | -- |
| Cash from Financing | 13.00K | 215.90K | 90.10K | 1.11M | -36.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -388.60K | -421.90K | 512.60K | 405.70K | -255.30K |
